Simvastatin-induced rhabdomyolysis in a patient with chronic renal failure

American Journal of Nephrology

Volumn 20, Issue 3, 2000, Pages 212-213

  Shohaib, Saad Al ^a  

^a KING KHALID NATIONAL GUARD HOSPITAL   (Saudi Arabia)

Author keywords

Acute renal failure; Chronic renal failure; Rhabdomyolysis; Simvastatin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

AGED; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LUNG EDEMA; MYALGIA; MYOGLOBINURIA; MYOPATHY; MYOSITIS; OLIGURIA; PRIORITY JOURNAL; RHABDOMYOLYSIS;

EID: 0343526812     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013589     Document Type: Article

References (8)

1. Reynolds JEF: Simvastatin; in Reynolds JEF (ed): Martindale: The Extra Pharmacopoeia; ed 31. London, Royal Pharmaceutical Society, 1996, pp 1313-1314.
2. McEvoy GK: Simvastatin; in McEvoy GK (ed): AFHS Drug Information, 1997. Bethesda, American Society of Health Systems Pharmacists, 1997, pp 1363-1366.
3. Anderson PO, Knoben JE: HMG-CoA reductase inhibitors: Fluvastatin, lovastatin, pravastatin, simvastatin; in Anderson PO, Knoben JE (eds): Handbook of Clinical Drug Data, ed 8. Norwalk, Appleton & Lange, 1998, pp 298-307.
4. Deslypere JP, Delanghe J, Vermeulen A: Proteinuria as a complication of simvastatin treatment. Lancet 1990;336:1453.
5. Committee on Safety of Medicines/Medicines Control Agency: Rhabdomyolysis associated with lipid-lowering drugs. Curr Probl 1995;21: 3.
6. Deslypere JP, Vermeulen A: Rhabdomyolysis and simvastatin use. Ann Intern Med 1991; 114:342.
7. Berland Y, Vacher Coponat H, Durand C, Baz M, Laugier R, Musso JL: Rhabdomyolysis with simvastatin use. Nephron 1991;57:365-366.
8. Wanner C: HMG-CoA reductase inhibitor treatment in renal insufficiency. Nephrol Dial Transplant 1996;11:1951-1952.